GYKI 47261 dihydrochloride
Cat. No. 3099
Chemical Name: 4-(8-Chloro-2-methyl-11H-imidazo[1,
Biological ActivityNon-competitive AMPA receptor antagonist (IC50 = 2.5 μM). Displays broad spectrum anticonvulsive activity and neuroprotective effects in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Bibbiani et al (2005) Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Exp.Neurol. 196 422. PMID: 16203001.
Solyo (2001) Research on new AMPA antagonists of 2,3-benzodiazepine type. Pharmazie 25 (Suppl. 1) S62.
Abraham et al (2000) New non competitive AMPA antagonists. Bioorg.Med.Chem. 8 2127. PMID: 11003158.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses GYKI 47261 dihydrochloride from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: GYKI 47261 dihydrochloride, supplier, Non-competitive, AMPA, antagonists, Glutamate, Receptors, iGluR, Ionotropic, GYKI47261, dihydrochloride, Tocris Bioscience, AMPA Receptor Antagonist products
Find multiple products by catalog number
New Products in this Area
NMDA receptor modulator; metabolite of Ketamine hydrochloride (Cat. No.3131)2S,6S-Hydroxynorketamine hydrochloride
Potent AMPA agonist; ketamine metabolite2R,6R-Hydroxynorketamine hydrochloride
Potent AMPA agonist; ketamine metabolite(R)-Norketamine hydrochloride
NMDA receptor modulator; metabolite of Ketamine hydrochloride (Cat. No.3131).PEAQX tetrasodium salt
Potent NMDA receptor antagonist; NR2A selective
April 10 - 13, 2017